There are 2789 resources available
LBA49 - Efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC) and actionable genomic alterations (AGAs): Preliminary results from the phase I TROPION-PanTumor01 study
Presenter: Edward Garon
Session: Mini oral session - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
LBA50 - A randomized phase III study comparing cisplatin-pemetrexed (cis-pem) with carboplatin (C)-paclitaxel (P)-bevacizumab (B) in chemotherapy naïve patients (pts) with advanced KRAS mutated non-small cell lung cancer (NSCLC): NVALT22
Presenter: Anne-Marie Dingemans
Session: Mini oral session - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
LBA51 - EMPOWER-Lung 3: Cemiplimab in combination with platinum doublet chemotherapy for first-line (1L) treatment of advanced non-small cell lung cancer (NSCLC)
Presenter: Miranda Gogishvili
Session: Mini oral session - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
829MO - A gene signature to predict risk of transformation in patients with follicular lymphoma
Presenter: Ismael Fernandez-Miranda
Session: Mini oral session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
579MO - CheckMate 9KD cohort A2 final analysis: Nivolumab (NIVO) + rucaparib for chemotherapy (CT)-naïve metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Daniel Petrylak
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Introduction by the chair
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Yes
Presenter: Denis Soulieres
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
No
Presenter: Paolo Bossi
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Q&A
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast